Eric Crombez - Net Worth and Insider Trading
Eric Crombez Net Worth
The estimated net worth of Eric Crombez is at least $2 Million dollars as of 2024-11-13. Eric Crombez is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc and owns about 48,431 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $2 Million. Details can be seen in Eric Crombez's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Crombez has not made any transactions after 2024-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Crombez
Eric Crombez Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Crombez owns 1 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) .
Click here to see the complete history of Eric Crombez’s form 4 insider trades.
Insider Ownership Summary of Eric Crombez
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-05-02 | EVP and Chief Medical Officer |
Eric Crombez Latest Holdings Summary
Eric Crombez currently owns a total of 1 stock. Eric Crombez owns 48,431 shares of Ultragenyx Pharmaceutical Inc (RARE) as of May 2, 2024, with a value of $2 Million.
Latest Holdings of Eric Crombez
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2024-05-02 | 48,431 | 48.63 | 2,355,200 |
Holding Weightings of Eric Crombez
Eric Crombez Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Crombez has made a total of 3 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 354 shares on May 2, 2024, which brought Eric Crombez around $15,456.
Insider Trading History of Eric Crombez
- 1
Eric Crombez Trading Performance
Eric Crombez Ownership Network
Ownership Network List of Eric Crombez
Ownership Network Relation of Eric Crombez
Eric Crombez Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Eric Crombez is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Chief Financial Officer Howard Horn , director & 10 percent owner & President & CEO Emil D Kakkis , and Controller and PAO Theodore Alan Huizenga .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Eric Crombez made 3 insider transaction in Ultragenyx Pharmaceutical Inc (RARE) with a net sale of 1,734. Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Eric Crombez Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Crombez. You might contact Eric Crombez via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
